[Federal Register Volume 75, Number 171 (Friday, September 3, 2010)]
[Notices]
[Pages 54161-54162]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-22093]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and/or contract proposals 
and the discussions could disclose confidential trade secrets or 
commercial property such as patentable material, and personal 
information concerning individuals associated with the grant 
applications and/or contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Disparities, Cancer Risk and Prognostic Factors, PO1.
    Date: September 28-29, 2010.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Doubletree Hotel Bethesda (Formerly Holiday Inn Select), 
8120 Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Wlodek Lopaczynski, M.D., PhD, Scientific Review 
Officer, Research Programs Review Branch, Division of Extramural 
Activities, National Cancer Institute, 6116 Executive Blvd. Room 
8131, Bethesda, MD 20892, 301-594-1402, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SPORE in Sarcoma, Brain, Liver, Lung, and Prostate Cancers.
    Date: September 29-30, 2010.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Washington/Rockville, 1750 Rockville Pike, 
Rockville, MD 20852.
    Contact Person: Shamala K. Srinivas, PhD, Scientific Review 
Officer, Research Programs Review Branch, Division of Extramural 
Activities, National Cancer Institute, 6116 Executive Boulevard, 
Room 8123, Bethesda, MD 20892, 301-594-1224, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Preclinical Pharmacokinetic and Pharmacological Studies.
    Date: September 30-October 1, 2010.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: Bethesda North Marriott Hotel & Conference Center, 
Montgomery County Conference Center Facility, 5701 Marinelli Road, 
North Bethesda, MD 20852.
    Contact Person: Viatcheslav A Soldatenkov, M.D., PhD, Scientific 
Review Officer, Special Review and Logistics Branch, Division of 
Extramural Activities, National Cancer Institute, 6116 Executive 
Blvd Room 8057, Bethesda, MD 20892-8329, 301-451-4758, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Innovative Technology Development.
    Date: October 13, 2010.
    Time: 8 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Legacy Hotel and Meeting Center, 1775 Rockville Pike, 
Rockville, MD 20852.
    Contact Person: Jeffrey E. DeClue, PhD, Scientific Review 
Officer, Special Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 6116 Executive 
Boulevard, Room 8059, Bethesda, MD 20892-8329, 301-496-7904, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Quantitative Imaging for Evaluation of Responses to Cancer 
Therapies.
    Date: October 25, 2010.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Gaithersburg Hilton/Washington DC North, 620 Perry 
Parkway, Gaithersburg, MD 20877.
    Contact Person: Kenneth L. Bielat, PhD, Scientific Review 
Officer, Special Review Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, 6116 Executive Boulevard, 
Room 7147, Bethesda, MD 20892-8329, 301496-7576, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Strategic Partnering to Evaluate Cancer Signatures (SPECS II) 
(U01).
    Date: November 3, 2010.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Westin Alexandria, 400 Courthouse Square, Alexandria, VA 
22314.
    Contact Person: Marvin L Salin, PhD, Scientific Review Officer, 
Special Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, NIH,

[[Page 54162]]

6116 Executive Boulevard, Room 7073, Bethesda, MD 20892-8329, 301-
496-0694, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: August 26, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-22093 Filed 9-2-10; 8:45 am]
BILLING CODE 4140-01-P